 | • レポートコード：MRC2-11QY05022 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は獣医用ワクチンのグローバル市場について調査・分析したレポートです。種類別（不活化ワクチン、弱毒生ワクチン、複合ワクチン、トキソイドワクチン、組換えワクチン、DNAワクチン）市場規模、用途別（獣医クリニック、獣医病院、獣医研究所、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別獣医用ワクチンの競争状況、市場シェア ・世界の獣医用ワクチン市場：種類別市場規模 2015年-2020年（不活化ワクチン、弱毒生ワクチン、複合ワクチン、トキソイドワクチン、組換えワクチン、DNAワクチン） ・世界の獣医用ワクチン市場：種類別市場規模予測 2021年-2026年（不活化ワクチン、弱毒生ワクチン、複合ワクチン、トキソイドワクチン、組換えワクチン、DNAワクチン） ・世界の獣医用ワクチン市場：用途別市場規模 2015年-2020年（獣医クリニック、獣医病院、獣医研究所、小売薬局） ・世界の獣医用ワクチン市場：用途別市場規模予測 2021年-2026年（獣医クリニック、獣医病院、獣医研究所、小売薬局） ・北米の獣医用ワクチン市場分析：米国、カナダ ・ヨーロッパの獣医用ワクチン市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの獣医用ワクチン市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の獣医用ワクチン市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの獣医用ワクチン市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Elanco、Merck、Merial、Zoetis、Advaxis、AmpliPhi Biosciences、Aratana Therapeutics、ARKO Labs、Bayer、CanFel Therapeutics、Ceva Animal Health、Colorado Serum、Epitopix、Genus、Hygieia Biological Laboratories、ImmuCell、Nexvet、Nuovo Biologics、UBI、Valneva、Vetoquinol、Virbac ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens.
The global veterinary vaccines market is expected to benefit from the growing concern over food safety. The dependency on livestock products like meat, milk, and other products is increasing, and the mortality rate associated with infection transmission from animals to humans through these products is alarming. These factors are driving the vendors to invest in R&D to improve and expand their product portfolios, thereby driving the market growth.
Market Analysis and Insights: Global Veterinary Vaccines Market
The global Veterinary Vaccines market size is projected to reach US$ 7198.6 million by 2026, from US$ 6692.6 million in 2020, at a CAGR of 7.0%% during 2021-2026.
Global Veterinary Vaccines Scope and Market Size
Veterinary Vaccines market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Veterinary Vaccines market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Elanco
Merck
Merial
Zoetis
Advaxis
AmpliPhi Biosciences
Aratana Therapeutics
ARKO Labs
Bayer
CanFel Therapeutics
Ceva Animal Health
Colorado Serum
Epitopix
Genus
Hygieia Biological Laboratories
ImmuCell
Nexvet
Nuovo Biologics
UBI
Valneva
Vetoquinol
Virbac
Market segment by Type, the product can be split into
Inactivated Vaccines
Live Attenuated Vaccines
Conjugate Vaccines
Toxoid Vaccines
Recombinant Vaccines
DNA Vaccines
Market segment by Application, split into
Veterinary Clinic
Veterinary Hospital
Veterinary Research Institute
Retail Pharmacy
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Veterinary Vaccines Revenue
1.4 Market by Type
1.4.1 Global Veterinary Vaccines Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Inactivated Vaccines
1.4.3 Live Attenuated Vaccines
1.4.4 Conjugate Vaccines
1.4.5 Toxoid Vaccines
1.4.6 Recombinant Vaccines
1.4.7 DNA Vaccines
1.5 Market by Application
1.5.1 Global Veterinary Vaccines Market Share by Application: 2020 VS 2026
1.5.2 Veterinary Clinic
1.5.3 Veterinary Hospital
1.5.4 Veterinary Research Institute
1.5.5 Retail Pharmacy
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Vaccines Market Perspective (2015-2026)
2.2 Global Veterinary Vaccines Growth Trends by Regions
2.2.1 Veterinary Vaccines Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Veterinary Vaccines Historic Market Share by Regions (2015-2020)
2.2.3 Veterinary Vaccines Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Veterinary Vaccines Market Growth Strategy
2.3.6 Primary Interviews with Key Veterinary Vaccines Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Vaccines Players by Market Size
3.1.1 Global Top Veterinary Vaccines Players by Revenue (2015-2020)
3.1.2 Global Veterinary Vaccines Revenue Market Share by Players (2015-2020)
3.1.3 Global Veterinary Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Veterinary Vaccines Market Concentration Ratio
3.2.1 Global Veterinary Vaccines Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Veterinary Vaccines Revenue in 2019
3.3 Veterinary Vaccines Key Players Head office and Area Served
3.4 Key Players Veterinary Vaccines Product Solution and Service
3.5 Date of Enter into Veterinary Vaccines Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Veterinary Vaccines Historic Market Size by Type (2015-2020)
4.2 Global Veterinary Vaccines Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Veterinary Vaccines Market Size by Application (2015-2020)
5.2 Global Veterinary Vaccines Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Veterinary Vaccines Market Size (2015-2020)
6.2 Veterinary Vaccines Key Players in North America (2019-2020)
6.3 North America Veterinary Vaccines Market Size by Type (2015-2020)
6.4 North America Veterinary Vaccines Market Size by Application (2015-2020)
7 Europe
7.1 Europe Veterinary Vaccines Market Size (2015-2020)
7.2 Veterinary Vaccines Key Players in Europe (2019-2020)
7.3 Europe Veterinary Vaccines Market Size by Type (2015-2020)
7.4 Europe Veterinary Vaccines Market Size by Application (2015-2020)
8 China
8.1 China Veterinary Vaccines Market Size (2015-2020)
8.2 Veterinary Vaccines Key Players in China (2019-2020)
8.3 China Veterinary Vaccines Market Size by Type (2015-2020)
8.4 China Veterinary Vaccines Market Size by Application (2015-2020)
9 Japan
9.1 Japan Veterinary Vaccines Market Size (2015-2020)
9.2 Veterinary Vaccines Key Players in Japan (2019-2020)
9.3 Japan Veterinary Vaccines Market Size by Type (2015-2020)
9.4 Japan Veterinary Vaccines Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Veterinary Vaccines Market Size (2015-2020)
10.2 Veterinary Vaccines Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Veterinary Vaccines Market Size by Type (2015-2020)
10.4 Southeast Asia Veterinary Vaccines Market Size by Application (2015-2020)
11 India
11.1 India Veterinary Vaccines Market Size (2015-2020)
11.2 Veterinary Vaccines Key Players in India (2019-2020)
11.3 India Veterinary Vaccines Market Size by Type (2015-2020)
11.4 India Veterinary Vaccines Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Veterinary Vaccines Market Size (2015-2020)
12.2 Veterinary Vaccines Key Players in Central & South America (2019-2020)
12.3 Central & South America Veterinary Vaccines Market Size by Type (2015-2020)
12.4 Central & South America Veterinary Vaccines Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Elanco
13.1.1 Elanco Company Details
13.1.2 Elanco Business Overview
13.1.3 Elanco Veterinary Vaccines Introduction
13.1.4 Elanco Revenue in Veterinary Vaccines Business (2015-2020))
13.1.5 Elanco Recent Development
13.2 Merck
13.2.1 Merck Company Details
13.2.2 Merck Business Overview
13.2.3 Merck Veterinary Vaccines Introduction
13.2.4 Merck Revenue in Veterinary Vaccines Business (2015-2020)
13.2.5 Merck Recent Development
13.3 Merial
13.3.1 Merial Company Details
13.3.2 Merial Business Overview
13.3.3 Merial Veterinary Vaccines Introduction
13.3.4 Merial Revenue in Veterinary Vaccines Business (2015-2020)
13.3.5 Merial Recent Development
13.4 Zoetis
13.4.1 Zoetis Company Details
13.4.2 Zoetis Business Overview
13.4.3 Zoetis Veterinary Vaccines Introduction
13.4.4 Zoetis Revenue in Veterinary Vaccines Business (2015-2020)
13.4.5 Zoetis Recent Development
13.5 Advaxis
13.5.1 Advaxis Company Details
13.5.2 Advaxis Business Overview
13.5.3 Advaxis Veterinary Vaccines Introduction
13.5.4 Advaxis Revenue in Veterinary Vaccines Business (2015-2020)
13.5.5 Advaxis Recent Development
13.6 AmpliPhi Biosciences
13.6.1 AmpliPhi Biosciences Company Details
13.6.2 AmpliPhi Biosciences Business Overview
13.6.3 AmpliPhi Biosciences Veterinary Vaccines Introduction
13.6.4 AmpliPhi Biosciences Revenue in Veterinary Vaccines Business (2015-2020)
13.6.5 AmpliPhi Biosciences Recent Development
13.7 Aratana Therapeutics
13.7.1 Aratana Therapeutics Company Details
13.7.2 Aratana Therapeutics Business Overview
13.7.3 Aratana Therapeutics Veterinary Vaccines Introduction
13.7.4 Aratana Therapeutics Revenue in Veterinary Vaccines Business (2015-2020)
13.7.5 Aratana Therapeutics Recent Development
13.8 ARKO Labs
13.8.1 ARKO Labs Company Details
13.8.2 ARKO Labs Business Overview
13.8.3 ARKO Labs Veterinary Vaccines Introduction
13.8.4 ARKO Labs Revenue in Veterinary Vaccines Business (2015-2020)
13.8.5 ARKO Labs Recent Development
13.9 Bayer
13.9.1 Bayer Company Details
13.9.2 Bayer Business Overview
13.9.3 Bayer Veterinary Vaccines Introduction
13.9.4 Bayer Revenue in Veterinary Vaccines Business (2015-2020)
13.9.5 Bayer Recent Development
13.10 CanFel Therapeutics
13.10.1 CanFel Therapeutics Company Details
13.10.2 CanFel Therapeutics Business Overview
13.10.3 CanFel Therapeutics Veterinary Vaccines Introduction
13.10.4 CanFel Therapeutics Revenue in Veterinary Vaccines Business (2015-2020)
13.10.5 CanFel Therapeutics Recent Development
13.11 Ceva Animal Health
10.11.1 Ceva Animal Health Company Details
10.11.2 Ceva Animal Health Business Overview
10.11.3 Ceva Animal Health Veterinary Vaccines Introduction
10.11.4 Ceva Animal Health Revenue in Veterinary Vaccines Business (2015-2020)
10.11.5 Ceva Animal Health Recent Development
13.12 Colorado Serum
10.12.1 Colorado Serum Company Details
10.12.2 Colorado Serum Business Overview
10.12.3 Colorado Serum Veterinary Vaccines Introduction
10.12.4 Colorado Serum Revenue in Veterinary Vaccines Business (2015-2020)
10.12.5 Colorado Serum Recent Development
13.13 Epitopix
10.13.1 Epitopix Company Details
10.13.2 Epitopix Business Overview
10.13.3 Epitopix Veterinary Vaccines Introduction
10.13.4 Epitopix Revenue in Veterinary Vaccines Business (2015-2020)
10.13.5 Epitopix Recent Development
13.14 Genus
10.14.1 Genus Company Details
10.14.2 Genus Business Overview
10.14.3 Genus Veterinary Vaccines Introduction
10.14.4 Genus Revenue in Veterinary Vaccines Business (2015-2020)
10.14.5 Genus Recent Development
13.15 Hygieia Biological Laboratories
10.15.1 Hygieia Biological Laboratories Company Details
10.15.2 Hygieia Biological Laboratories Business Overview
10.15.3 Hygieia Biological Laboratories Veterinary Vaccines Introduction
10.15.4 Hygieia Biological Laboratories Revenue in Veterinary Vaccines Business (2015-2020)
10.15.5 Hygieia Biological Laboratories Recent Development
13.16 ImmuCell
10.16.1 ImmuCell Company Details
10.16.2 ImmuCell Business Overview
10.16.3 ImmuCell Veterinary Vaccines Introduction
10.16.4 ImmuCell Revenue in Veterinary Vaccines Business (2015-2020)
10.16.5 ImmuCell Recent Development
13.17 Nexvet
10.17.1 Nexvet Company Details
10.17.2 Nexvet Business Overview
10.17.3 Nexvet Veterinary Vaccines Introduction
10.17.4 Nexvet Revenue in Veterinary Vaccines Business (2015-2020)
10.17.5 Nexvet Recent Development
13.18 Nuovo Biologics
10.18.1 Nuovo Biologics Company Details
10.18.2 Nuovo Biologics Business Overview
10.18.3 Nuovo Biologics Veterinary Vaccines Introduction
10.18.4 Nuovo Biologics Revenue in Veterinary Vaccines Business (2015-2020)
10.18.5 Nuovo Biologics Recent Development
13.19 UBI
10.19.1 UBI Company Details
10.19.2 UBI Business Overview
10.19.3 UBI Veterinary Vaccines Introduction
10.19.4 UBI Revenue in Veterinary Vaccines Business (2015-2020)
10.19.5 UBI Recent Development
13.20 Valneva
10.20.1 Valneva Company Details
10.20.2 Valneva Business Overview
10.20.3 Valneva Veterinary Vaccines Introduction
10.20.4 Valneva Revenue in Veterinary Vaccines Business (2015-2020)
10.20.5 Valneva Recent Development
13.21 Vetoquinol
10.21.1 Vetoquinol Company Details
10.21.2 Vetoquinol Business Overview
10.21.3 Vetoquinol Veterinary Vaccines Introduction
10.21.4 Vetoquinol Revenue in Veterinary Vaccines Business (2015-2020)
10.21.5 Vetoquinol Recent Development
13.22 Virbac
10.22.1 Virbac Company Details
10.22.2 Virbac Business Overview
10.22.3 Virbac Veterinary Vaccines Introduction
10.22.4 Virbac Revenue in Veterinary Vaccines Business (2015-2020)
10.22.5 Virbac Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Veterinary Vaccines Key Market Segments
Table 2. Key Players Covered: Ranking by Veterinary Vaccines Revenue
Table 3. Ranking of Global Top Veterinary Vaccines Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Veterinary Vaccines Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Inactivated Vaccines
Table 6. Key Players of Live Attenuated Vaccines
Table 7. Key Players of Conjugate Vaccines
Table 8. Key Players of Toxoid Vaccines
Table 9. Key Players of Recombinant Vaccines
Table 10. Key Players of DNA Vaccines
Table 11. Global Veterinary Vaccines Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Veterinary Vaccines Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Veterinary Vaccines Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Veterinary Vaccines Market Share by Regions (2015-2020)
Table 15. Global Veterinary Vaccines Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Veterinary Vaccines Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Veterinary Vaccines Market Growth Strategy
Table 21. Main Points Interviewed from Key Veterinary Vaccines Players
Table 22. Global Veterinary Vaccines Revenue by Players (2015-2020) (Million US$)
Table 23. Global Veterinary Vaccines Market Share by Players (2015-2020)
Table 24. Global Top Veterinary Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Vaccines as of 2019)
Table 25. Global Veterinary Vaccines by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Veterinary Vaccines Product Solution and Service
Table 28. Date of Enter into Veterinary Vaccines Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Veterinary Vaccines Market Size by Type (2015-2020) (Million US$)
Table 31. Global Veterinary Vaccines Market Size Share by Type (2015-2020)
Table 32. Global Veterinary Vaccines Revenue Market Share by Type (2021-2026)
Table 33. Global Veterinary Vaccines Market Size Share by Application (2015-2020)
Table 34. Global Veterinary Vaccines Market Size by Application (2015-2020) (Million US$)
Table 35. Global Veterinary Vaccines Market Size Share by Application (2021-2026)
Table 36. North America Key Players Veterinary Vaccines Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Veterinary Vaccines Market Share (2019-2020)
Table 38. North America Veterinary Vaccines Market Size by Type (2015-2020) (Million US$)
Table 39. North America Veterinary Vaccines Market Share by Type (2015-2020)
Table 40. North America Veterinary Vaccines Market Size by Application (2015-2020) (Million US$)
Table 41. North America Veterinary Vaccines Market Share by Application (2015-2020)
Table 42. Europe Key Players Veterinary Vaccines Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Veterinary Vaccines Market Share (2019-2020)
Table 44. Europe Veterinary Vaccines Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Veterinary Vaccines Market Share by Type (2015-2020)
Table 46. Europe Veterinary Vaccines Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Veterinary Vaccines Market Share by Application (2015-2020)
Table 48. China Key Players Veterinary Vaccines Revenue (2019-2020) (Million US$)
Table 49. China Key Players Veterinary Vaccines Market Share (2019-2020)
Table 50. China Veterinary Vaccines Market Size by Type (2015-2020) (Million US$)
Table 51. China Veterinary Vaccines Market Share by Type (2015-2020)
Table 52. China Veterinary Vaccines Market Size by Application (2015-2020) (Million US$)
Table 53. China Veterinary Vaccines Market Share by Application (2015-2020)
Table 54. Japan Key Players Veterinary Vaccines Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Veterinary Vaccines Market Share (2019-2020)
Table 56. Japan Veterinary Vaccines Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Veterinary Vaccines Market Share by Type (2015-2020)
Table 58. Japan Veterinary Vaccines Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Veterinary Vaccines Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Veterinary Vaccines Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Veterinary Vaccines Market Share (2019-2020)
Table 62. Southeast Asia Veterinary Vaccines Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Veterinary Vaccines Market Share by Type (2015-2020)
Table 64. Southeast Asia Veterinary Vaccines Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Veterinary Vaccines Market Share by Application (2015-2020)
Table 66. India Key Players Veterinary Vaccines Revenue (2019-2020) (Million US$)
Table 67. India Key Players Veterinary Vaccines Market Share (2019-2020)
Table 68. India Veterinary Vaccines Market Size by Type (2015-2020) (Million US$)
Table 69. India Veterinary Vaccines Market Share by Type (2015-2020)
Table 70. India Veterinary Vaccines Market Size by Application (2015-2020) (Million US$)
Table 71. India Veterinary Vaccines Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Veterinary Vaccines Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Veterinary Vaccines Market Share (2019-2020)
Table 74. Central & South America Veterinary Vaccines Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Veterinary Vaccines Market Share by Type (2015-2020)
Table 76. Central & South America Veterinary Vaccines Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Veterinary Vaccines Market Share by Application (2015-2020)
Table 78. Elanco Company Details
Table 79. Elanco Business Overview
Table 80. Elanco Product
Table 81. Elanco Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 82. Elanco Recent Development
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Product
Table 86. Merck Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 87. Merck Recent Development
Table 88. Merial Company Details
Table 89. Merial Business Overview
Table 90. Merial Product
Table 91. Merial Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 92. Merial Recent Development
Table 93. Zoetis Company Details
Table 94. Zoetis Business Overview
Table 95. Zoetis Product
Table 96. Zoetis Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 97. Zoetis Recent Development
Table 98. Advaxis Company Details
Table 99. Advaxis Business Overview
Table 100. Advaxis Product
Table 101. Advaxis Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 102. Advaxis Recent Development
Table 103. AmpliPhi Biosciences Company Details
Table 104. AmpliPhi Biosciences Business Overview
Table 105. AmpliPhi Biosciences Product
Table 106. AmpliPhi Biosciences Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 107. AmpliPhi Biosciences Recent Development
Table 108. Aratana Therapeutics Company Details
Table 109. Aratana Therapeutics Business Overview
Table 110. Aratana Therapeutics Product
Table 111. Aratana Therapeutics Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 112. Aratana Therapeutics Recent Development
Table 113. ARKO Labs Business Overview
Table 114. ARKO Labs Product
Table 115. ARKO Labs Company Details
Table 116. ARKO Labs Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 117. ARKO Labs Recent Development
Table 118. Bayer Company Details
Table 119. Bayer Business Overview
Table 120. Bayer Product
Table 121. Bayer Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 122. Bayer Recent Development
Table 123. CanFel Therapeutics Company Details
Table 124. CanFel Therapeutics Business Overview
Table 125. CanFel Therapeutics Product
Table 126. CanFel Therapeutics Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 127. CanFel Therapeutics Recent Development
Table 128. Ceva Animal Health Company Details
Table 129. Ceva Animal Health Business Overview
Table 130. Ceva Animal Health Product
Table 131. Ceva Animal Health Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 132. Ceva Animal Health Recent Development
Table 133. Colorado Serum Company Details
Table 134. Colorado Serum Business Overview
Table 135. Colorado Serum Product
Table 136. Colorado Serum Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 137. Colorado Serum Recent Development
Table 138. Epitopix Company Details
Table 139. Epitopix Business Overview
Table 140. Epitopix Product
Table 141. Epitopix Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 142. Epitopix Recent Development
Table 143. Genus Company Details
Table 144. Genus Business Overview
Table 145. Genus Product
Table 146. Genus Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 147. Genus Recent Development
Table 148. Hygieia Biological Laboratories Company Details
Table 149. Hygieia Biological Laboratories Business Overview
Table 150. Hygieia Biological Laboratories Product
Table 151. Hygieia Biological Laboratories Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 152. Hygieia Biological Laboratories Recent Development
Table 153. ImmuCell Company Details
Table 154. ImmuCell Business Overview
Table 155. ImmuCell Product
Table 156. ImmuCell Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 157. ImmuCell Recent Development
Table 158. Nexvet Company Details
Table 159. Nexvet Business Overview
Table 160. Nexvet Product
Table 161. Nexvet Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 162. Nexvet Recent Development
Table 163. Nuovo Biologics Company Details
Table 164. Nuovo Biologics Business Overview
Table 165. Nuovo Biologics Product
Table 166. Nuovo Biologics Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 167. Nuovo Biologics Recent Development
Table 168. UBI Company Details
Table 169. UBI Business Overview
Table 170. UBI Product
Table 171. UBI Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 172. UBI Recent Development
Table 173. Valneva Company Details
Table 174. Valneva Business Overview
Table 175. Valneva Product
Table 176. Valneva Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 177. Valneva Recent Development
Table 178. Vetoquinol Company Details
Table 179. Vetoquinol Business Overview
Table 180. Vetoquinol Product
Table 181. Vetoquinol Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 182. Vetoquinol Recent Development
Table 183. Virbac Company Details
Table 184. Virbac Business Overview
Table 185. Virbac Product
Table 186. Virbac Revenue in Veterinary Vaccines Business (2015-2020) (Million US$)
Table 187. Virbac Recent Development
Table 188. Research Programs/Design for This Report
Table 189. Key Data Information from Secondary Sources
Table 190. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Veterinary Vaccines Market Share by Type: 2020 VS 2026
Figure 2. Inactivated Vaccines Features
Figure 3. Live Attenuated Vaccines Features
Figure 4. Conjugate Vaccines Features
Figure 5. Toxoid Vaccines Features
Figure 6. Recombinant Vaccines Features
Figure 7. DNA Vaccines Features
Figure 8. Global Veterinary Vaccines Market Share by Application: 2020 VS 2026
Figure 9. Veterinary Clinic Case Studies
Figure 10. Veterinary Hospital Case Studies
Figure 11. Veterinary Research Institute Case Studies
Figure 12. Retail Pharmacy Case Studies
Figure 13. Veterinary Vaccines Report Years Considered
Figure 14. Global Veterinary Vaccines Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global Veterinary Vaccines Market Share by Regions: 2020 VS 2026
Figure 16. Global Veterinary Vaccines Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global Veterinary Vaccines Market Share by Players in 2019
Figure 19. Global Top Veterinary Vaccines Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Vaccines as of 2019
Figure 20. The Top 10 and 5 Players Market Share by Veterinary Vaccines Revenue in 2019
Figure 21. North America Veterinary Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe Veterinary Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China Veterinary Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan Veterinary Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia Veterinary Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India Veterinary Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America Veterinary Vaccines Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Bottom-up and Top-down Approaches for This Report
Figure 29. Data Triangulation
Figure 30. Key Executives Interviewed
獣医/動物用ワクチンの世界市場（～2026年） The market is classified into live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines and other vaccines on the basis of technology. In 2017, in terms of value, Europe is expected to account for the largest share of the global animal vaccines market, followed by North A…- ワクチン・予防接種の世界市場（～2026年） Vaccination is the administration of antigenic material (avaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate infectious disease. The increasing popularity of pediatric, travel, addiction, and pediatric combination vaccin…
- フルミストワクチンの世界市場（～2026年） An attenuated vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable (or "live"). Attenuation takes an infectious agent and alters it so that it becomes harmless or less virulent. These vaccines contrast to those produced by "killing" the virus (inactivated…
- 細菌ワクチンの世界市場（～2026年） Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Different types of bacterial vaccines include, capsular polysaccharide vaccines, toxoid vaccines, purified protein vaccines, live attenuated bacterial vaccines, and killed bacterial vaccines. Rise in prevalence…
- ワクチンデリバリーの世界市場（～2026年） Market Analysis and Insights: Global Vaccines Delivery Market The global Vaccines Delivery market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Vaccines Delivery Scope and Market Size Vaccines Delivery market is segmented b…